Knowledge Network Node

Research on chinese medical treatment of refractory idiopathic thrombocytopenic purpuraChinese Full Text

ZANG Xiang,ZHOU Yu-hong(Zhejiang Chinese Medical University Affiliated First Hospital,Hangzhou 310006,Zhejiang,China)

Abstract: Refractory idiopathic thrombocytopenic purpura resists to glucocorticoids and splenectomy,resulting in difficulty in clinical treatment.Though choices are various,clinical effect is not ideal.Application of Rituximab and TPO,Romiplostin,Eltrombopag,IL-11 impoves the result.Chinese medical treatment which based on"Huo","Xu" and "Yu" can reach better effect through reducing toxicity,increasing effect,stabilizing patient condition,decreasing relapse.
  • DOI:

    10.13193/j.archtcm.2012.08.95.zhangx.015

  • Series:

  • Subject:

  • Classification Code:

    R259

  • Mobile Reading
    Read on your phone instantly
    Step 1

    Scan QR Codes

    "Mobile CNKI-CNKI Express" App

    Step 2

    Open“CNKI Express”

    and click the scan icon in the upper left corner of the homepage.

    Step 3

    Scan QR Codes

    Read this article on your phone.

  • HTML
  • CAJ Download
  • PDF Download

Download the mobile appuse the app to scan this coderead the article.

Tips: Please download CAJViewer to view CAJ format full text.

Download: 308 Page: 1789-1792 Pagecount: 4 Size: 95K

Related Literature
  • Similar Article
  • Reader Recommendation
  • Associated Author